Specialty Pharmaceuticals

Drug Delivery
Technology

Kashiv Specialty Pharmaceuticals (KSP) is a wholly-owned subsidiary of Kashiv Biosciences, formed to develop complex generics, innovative drug delivery platforms, and novel 505(b)(2) drugs.

Strategic Development

Since the star of its operations in 2011, Kashiv under the leadership of top industry formulation scientists has developed several patented next generation oral drug delivery technologies, 15 high-value complex generic products successfully launched by a partner, and a proprietary clinical stage pipeline of five differentiated 505(b)(2) products targeting orphan and severe diseases. Kashiv has a growing pipeline of several new complex generics and new 505(b)(2) candidates undergoing feasibility testing and formulation development.

We are a People-Oriented
Organization

We are a fast-growing specialty pharmaceutical company providing an innovative environment and opportunities for professional growth.

We are a
People-Oriented
Organization

We are a fast-growing specialty pharmaceutical company providing an innovative environment and opportunities for professional growth.